BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10890896)

  • 1. Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
    Dantuma NP; Heessen S; Lindsten K; Jellne M; Masucci MG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8381-5. PubMed ID: 10890896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.
    Zhang M; Coffino P
    J Biol Chem; 2004 Mar; 279(10):8635-41. PubMed ID: 14688254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.
    Sharipo A; Imreh M; Leonchiks A; Brändén C; Masucci MG
    FEBS Lett; 2001 Jun; 499(1-2):137-42. PubMed ID: 11418128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat.
    Heessen S; Dantuma NP; Tessarz P; Jellne M; Masucci MG
    FEBS Lett; 2003 Dec; 555(2):397-404. PubMed ID: 14644450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat.
    Piechocki MP; Pilon SA; Kelly C; Wei WZ
    Cell Immunol; 2001 Sep; 212(2):138-49. PubMed ID: 11748930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.
    Tellam J; Sherritt M; Thomson S; Tellam R; Moss DJ; Burrows SR; Wiertz E; Khanna R
    J Biol Chem; 2001 Sep; 276(36):33353-60. PubMed ID: 11435434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
    Heessen S; Leonchiks A; Issaeva N; Sharipo A; Selivanova G; Masucci MG; Dantuma NP
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1532-7. PubMed ID: 11805282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.
    Leonchiks A; Stavropoulou V; Sharipo A; Masucci MG
    FEBS Lett; 2002 Jul; 522(1-3):93-8. PubMed ID: 12095625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin/proteasome system.
    Magnani M
    Nat Biotechnol; 2000 Aug; 18(8):807. PubMed ID: 10932130
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
    Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
    Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
    Masucci MG
    Oncogene; 2004 Mar; 23(11):2107-15. PubMed ID: 15021898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.
    Dai RM; Li CC
    Nat Cell Biol; 2001 Aug; 3(8):740-4. PubMed ID: 11483959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
    Krauer KG; Buck M; Belzer DK; Flanagan J; Chojnowski GM; Sculley TB
    Virology; 2004 Jan; 318(1):280-94. PubMed ID: 14972554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
    Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci MG
    Nat Med; 1998 Aug; 4(8):939-44. PubMed ID: 9701247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.
    Coppotelli G; Mughal N; Marescotti D; Masucci MG
    J Biol Chem; 2011 Jun; 286(22):19565-75. PubMed ID: 21471195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.
    Ito Y; Kondo E; Demachi-Okamura A; Akatsuka Y; Tsujimura K; Tanimoto M; Morishima Y; Takahashi T; Kuzushima K
    J Virol; 2006 Jan; 80(2):883-90. PubMed ID: 16378990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria.
    Koh KW; Lehming N; Seah GT
    Mol Immunol; 2009 Apr; 46(7):1312-8. PubMed ID: 19128836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.